CalcMyPeptide retweetledi

🚨 🚨 🚨 BREAKING $LLY $NVO $HIMS $WW
FDA ISSUES MASSIVE UPDATE IN ENFORCEMENT AGAINST COMPOUNDED GLP-1.
• SAME DRUG, SAME DOSE, SAME INJECTION = CONSIDERED A COPY
• ADDING B12 DOESN’T MAKE IT “DIFFERENT”
• ENFORCEMENT TOLERANCE CAPPED AT JUST 4 SCRIPTS PER MONTH
• TIRZEPATIDE AND SEMAGLUTIDE NO LONGER QUALIFY FOR BULK 503B COMPOUNDING
THE CRACKDOWN IS HERE… FOLLOW FOR MORE UPDATES…
H/t: @ResearchPulse1
English


